Camber (Camber)
Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 31722-591
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 31722-591). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Metoprololsuccinatefigure1 (Metoprololsuccinatefigure1)
Metoprololsuccinatestructure (Metoprololsuccinatestructure)
Metoprololsuccinatetablets100mg (Metoprololsuccinatetablets100mg)
Metoprolol Succinate Extended-Release Tablets, USP with 30 tablets in each bottle is a medication sold by Camber Pharmaceuticals, Inc. Each tablet contains 95 mg of metoprolol succinate, USP which is similar to 100 mg of metoprolol tartrate, USP. The package insert must be referred to for usual dosage instructions. The warning instructs users to keep the medication out of children's reach and the storage conditions of these tablets should be at room temperature. The product should be kept in properly sealed containers. The company's information is provided, including their contact number and license number. The medication is manufactured by Hetero Labs Limited in Hyderabad, India.*
Metoprololsuccinatetablets200mg (Metoprololsuccinatetablets200mg)
This is a description of a medication called Metoprolol Succinate Extended-Release Tablets. The tablets are used for treating heart-related issues and each tablet contains 190 mg of metoprolol succinate which is equivalent to 200 mg of metoprolol tartrate. The text also provides important information about dosage, storage, and manufacturer details.*
Metoprololsuccinatetablets25mg (Metoprololsuccinatetablets25mg)
This is a description of a medication called Metoprolol Succinate Extended-Release Tablets, USP. This medication comes in the form of extended-release, film-coated tablets with a strength of 25mg. It contains 23.75 mg metoprolol succinate, USP equivalent to 25 mg metoprolol tartrate, USP. The dosage to be taken should be as per the package insert. It's a prescription-only medicine and should be kept out of the reach of children. It should be stored at a temperature between 20°C to 25°C. It's manufactured by Hetero Labs Limited, Hyderabad, India, and supplied by Camber Pharmaceuticals, Inc, Piscataway, NJ.*
Metoprololsuccinatetablets50mg (Metoprololsuccinatetablets50mg)
Metoprolol Succinate Extended-Release Tablets, USP is a prescription medication that comes in a package of 30 tablets. It contains 47.5 mg of metoprolol succinate and is equivalent to 50 mg of metoprolol tartrate. Users must keep this medication out of the reach of children and store it at 20° to 25°C (68° to 77°F). It should be preserved in tight containers. Camber Pharmaceuticals, Inc. manufactures it for Hetero Labs Limited, based in Hyderabad, India. The packaging also includes the appropriate contact information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
